TLR7-AGONISTEN

Patent europeic · EP3801538 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3801538
Numer da la dumonda
EP19806874
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
24-05-2019
Publitgà
14-04-2021
Concedì
02-10-2024
La protecziun finescha il pli tard
23-05-2039
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07D 473/18 (2006.01)
A61K 31/522 (2006.01)
A61P 31/12 (2006.01)
A61P 35/00 (2006.01)
C07H 19/16 (2006.01)
C07H 19/167 (2006.01)
C07H 19/173 (2006.01)
Prioritad
US 201862676433 P 25.05.2018
Dumonda PCT
PCT/US2019/033896 24.05.2019
Publicaziun PCT
WO2019/226977 28.11.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 13-08-2025

    Midada

    Published in Swissreg on 13.08.2025

  3. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  4. 19-12-2024

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 19.12.2024

  5. 03-10-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Partidas

Possessur

Primmune Therapeutics, Inc.

Jlabs San Diego 3210 Merryfield Row, San Diego, CA 92121, US

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

WEBBER, Stephen, E.

San Diego, CA 92122, US

APPLEMAN, James, Richard

San Diego, CA 92117, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.